(Q40434852)

20 September 2017

1 reference

title

Hormone replacement therapy and cardiovascular risk: the cardiovascular physicians' viewpoint (English)

1 reference

Hormone Replacement Therapy

20 September 2017

main subject

1 reference

G. Y. Lip

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7595178

2 June 2024

G. Beevers

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7595178

2 June 2024

J. Zarifis

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7595178

2 June 2024

language of work or name

English

0 references

publication date

1 November 1995

1 reference

full work available at URL

20 September 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2796.1995.tb01216.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7595178

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2796.1995.tb01216.x

2 June 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2796.1995.tb01216.x

2 June 2024

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Journal of Internal Medicine

2 June 2024

published in

1 reference

20 September 2017

volume

238

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

389-399

1 reference

Menopause and coronary heart disease. The Framingham Study

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01216.X

Hormone therapy to prevent disease and prolong life in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01216.X

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01216.X

Postmenopausal estrogen use and coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01216.X

21 January 2018

The cholesterol papers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01216.X

Estrogen modulates responses of atherosclerotic coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01216.X

Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01216.X

Hypertension, oral contraceptive agents, and conjugated estrogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01216.X

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01216.X

Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01216.X

Postmenopausal estrogen and prevention bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.1995.TB01216.X

Menopause and the risk of coronary heart disease in women

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Coronary heart disease, the menopause, and hormone replacement therapy

2 June 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Guidelines for counseling postmenopausal women about preventive hormone therapy. American College of Physicians

2 June 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Hormone replacement therapy in general practice: a survey of doctors in the MRC's general practice research framework

2 June 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Mortality among women participating in the Oxford/Family Planning Association contraceptive study

2 June 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Risk factors for acute myocardial infarction in women: evidence from the Royal College of General Practitioners' oral contraception study

2 June 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

A prospective study of postmenopausal estrogen therapy and coronary heart disease

2 June 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort

2 June 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Myocardial infarction and estrogen therapy in post-menopausal women

2 June 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

2 June 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Menopausal oestrogen therapy and protection from death from ischaemic heart disease

2 June 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Postmenopausal use of estrogen and occlusion of coronary arteries

2 June 2024

24

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Risk factors and noncontraceptive estrogen use in women with and without coronary disease

2 June 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study

2 June 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

2 June 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease

2 June 2024

31

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Effect of estradiol-17β on blood flow to reproductive and nonreproductive tissues in pregnant ewes

2 June 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Reversal of acetylcholine effect on atherosclerotic coronary arteries by estrogen: pharmacologic phenomenon of clinical importance?

2 June 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

The effects of hormone replacement therapy in normal postmenopausal women: measurements of Doppler-derived parameters of aortic flow

2 June 2024

39

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease

2 June 2024

40

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Oral Contraception and Increased Risk of Cerebral Ischemia or Thrombosis

2 June 2024

41

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Estrogen use and stroke risk in postmenopausal women

2 June 2024

42

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Postmenopausal oestrogen treatment and stroke: a prospective study

2 June 2024

43

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Blood pressure and contraceptive use.

2 June 2024

48

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Blood Pressure in Women Taking Oral Contraceptives

2 June 2024

49

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Effects of natural estrogen/gestagen and thiazide on coronary risk factors in normal postmenopausal women. A 2-year double-blind placebo study

2 June 2024

50

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

A prospective, controlled trial of six forms of hormone replacement therapy given to postmenopausal women

2 June 2024

51

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Estrogen use and blood pressure in later life

2 June 2024

53

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Effects of long-term estrogen replacement therapy. I. Metabolic effects

2 June 2024

56

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Effects of natural oestrogen therapy on blood pressure and renin-angiotensin system in normotensive and hypertensive menopausal women

2 June 2024

57

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

The influence of menopause on blood pressure

2 June 2024

59

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Importance of body weight in determining rise and level of blood pressure in postmenopausal women

2 June 2024

60

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Investigation of relation between use of oral contraceptives and thromboembolic disease

2 June 2024

61

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Investigation of Relation between Use of Oral Contraceptives and Thromboembolic Disease. A Further Report

2 June 2024

62

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Thromboembolism and oral contraceptives: an epidemiologic case-control study

2 June 2024

63

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center

2 June 2024

64

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Estrogen replacement therapy is not conducive of venous thromboembolism

2 June 2024

65

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen

2 June 2024

66

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

The impact of female hormone usage on the lipid profile. The Framingham Offspring Study

2 June 2024

68

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol

2 June 2024

69

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Estrogen and coronary heart disease in women

2 June 2024

70

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Plasma fibrinogen and its correlates in Japanese and US population samples

2 June 2024

74

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Effects of different progestogens on lipoproteins during postmenopausal replacement therapy

2 June 2024

76

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Post-menopausal hormone replacement therapy: effects of progestogens on serum lipids and lipoproteins. A review

2 June 2024

78

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Attitudes towards and level of information on perimenopausal and postmenopausal hormone replacement therapy among Norwegian women

2 June 2024

79

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Menopause: a change for the better?

2 June 2024

82

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

Hormone replacement and cancer

2 June 2024

86

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

The risk of breast cancer associated with oral contraception and hormone replacement therapy

2 June 2024

88

1 reference

https://api.crossref.org/works/10.1111/J.1365-2796.1995.TB01216.X

2 June 2024

Identifiers

1 reference

20 September 2017

1 reference